We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Turning Immune Cells into Tiny Anti-Tumor Drug Factories

News   Dec 05, 2018 | Original story from the University of California San Diego School of Medicine

 
Turning Immune Cells into Tiny Anti-Tumor Drug Factories

UC San Diego School of Medicine researchers developed a method to use B cells to manufacture and secrete microRNA-containing vesicles and showed they can inhibit tumor growth in mice. Credit: UC San Diego Health

 
 
 

RELATED ARTICLES

Protein Switches Sides in Leukemia

News

Researchers have discovered that an epigenetic protein called EZH2 delays the development of acute myeloid leukemia (AML) but then switches sides once the disease is established to help maintain tumor growth.

READ MORE

3D Mammography Significantly Reduces Breast Biopsy Rates

News

The use of digital breast tomosynthesis (DBT), also known as 3D mammography, may significantly reduce the number of women who undergo breast biopsy for a non-cancerous lesion following an abnormal mammogram, according to a new study published in the journal Radiology.

READ MORE

Device Would Allow TB Dosing to Switch From Daily to Monthly

News

A drug delivery device is under development, which works by slowly releasing antibiotics directly into the patient's stomach. This would allow patients to switch from daily to monthly doses, reducing the burden of tuberculosis treatment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE